For: | Randhawa M, Gaughran G, Archer C, Pavli P, Morey A, Ali S, Yip D. Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case report. World J Clin Oncol 2019; 10(10): 350-357 [PMID: 31799150 DOI: 10.5306/wjco.v10.i10.350] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i10/350.htm |
Number | Citing Articles |
1 |
O. Gómez Escudero. Enterocolitis and other immunotherapy and targeted therapy-related gastrointestinal manifestations: A review for gastroenterologist. Revista de Gastroenterología de México (English Edition) 2024; 89(1): 89 doi: 10.1016/j.rgmxen.2023.11.001
|
2 |
Maria Paparoupa, Sophie Stupperich, Lisa Goerg-Reifenberg, Andreas Wittig, Frank Schuppert. Successful Treatment of an Immune-Mediated Colitis Induced by Checkpoint Inhibitor Therapy in a Patient with Advanced Melanoma. Case Reports in Gastroenterology 2020; 14(3): 554 doi: 10.1159/000511252
|
3 |
J. Jochmann, A. Fink, A. Stella, R. Feldmann, L. Kramer, C. Posch. Prevention of severe immune‐related colitis caused by combined immune checkpoint inhibition using vedolizumab: A case report. Journal of the European Academy of Dermatology and Venereology 2023; 37(7) doi: 10.1111/jdv.19028
|
4 |
Mar Riveiro-Barciela, Sabela Carballal, Álvaro Díaz-González, Míriam Mañosa, Javier Gallego-Plazas, Joaquín Cubiella, Paula Jiménez-Fonseca, María Varela, Luis Menchén, Bruno Sangro, Ana Fernández-Montes, Francisco Mesonero, Miguel Ángel Rodríguez-Gandía, Fernando Rivera, María-Carlota Londoño. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU. Gastroenterología y Hepatología (English Edition) 2024; 47(4): 401 doi: 10.1016/j.gastre.2023.10.003
|
5 |
Alba GUGLIELMO, Clara BERTUZZI, Eleonora SCAIOLI, Andrea BELLUZZI, Elena SABATTINI, Annalisa PATRIZI, Alessandro PILERI. Iatrogenic Kaposi sarcoma during tumor necrosis factor alpha inhibitors. Italian Journal of Dermatology and Venereology 2021; 156(1) doi: 10.23736/S2784-8671.20.06595-5
|
6 |
Anca Macovei Oprescu, Raluca Tulin, Iulian Slavu, Dana Paula Venter, Constantin Oprescu. Immune Checkpoint Inhibitor-Induced Gastrointestinal Toxicity: The Opinion of a Gastroenterologist. Cureus 2021; doi: 10.7759/cureus.19945
|
7 |
Ayaka Kaneoka, Etsuko Okada, Hitomi Sugino, Natsuko Saito-Sasaki, Daisuke Omoto, Motonobu Nakamura. Vedolizumab Attenuates Immune-Checkpoint-Therapy-Induced Infliximab-Refractory Colitis. Diagnostics 2022; 12(2): 480 doi: 10.3390/diagnostics12020480
|
8 |
Sae Ohwada, Keisuke Ishigami, Noriyuki Akutsu, Hiroshi Nakase. Pharmacological Treatments Available for Immune-Checkpoint-Inhibitor-Induced Colitis. Biomedicines 2022; 10(6): 1334 doi: 10.3390/biomedicines10061334
|
9 |
Mar Riveiro-Barciela, Sabela carballal, Álvaro Díaz-González, Miriam Mañosa, Javier Gallgo-Plazas, Joaquín Cubiella, Paula Jiménez-Fonseca, María Varela, Luis Menchén, Bruno Sangro, Ana Fernández-Montes, Francisco Mesonero, Miguel Ángel Rodríguez-Gandía, Fernando Rivera, María-Carlota Londoño. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU. Revista Española de Enfermedades Digestivas 2024; doi: 10.17235/reed.2024.10250/2024
|
10 |
Mar Riveiro-Barciela, Sabela Carballal, Álvaro Díaz-González, Míriam Mañosa, Javier Gallego-Plazas, Joaquín Cubiella, Paula Jiménez-Fonseca, María Varela, Luis Menchén, Bruno Sangro, Ana Fernández-Montes, Francisco Mesonero, Miguel Ángel Rodríguez-Gandía, Fernando Rivera, María-Carlota Londoño. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU. Gastroenterología y Hepatología 2024; 47(4): 401 doi: 10.1016/j.gastrohep.2023.10.009
|
11 |
O. Gómez-Escudero. Enterocolitis y otras manifestaciones de toxicidad gastrointestinal asociada a inmunoterapia y terapia blanco: una revisión para el gastroenterólogo. Revista de Gastroenterología de México 2024; 89(1): 89 doi: 10.1016/j.rgmx.2023.11.001
|
12 |
Hikaru Ishihara, Tatsuyuki Watanabe, Shinsuke Kumei, Keiichiro Kume, Ichiro Yoshikawa, Masaru Harada. A case of refractory immune checkpoint inhibitor-induced colitis improved by the treatment with vedolizumab and granulocyte–monocyte apheresis combination therapy. Clinical Journal of Gastroenterology 2024; 17(1): 46 doi: 10.1007/s12328-023-01887-7
|